These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 33942470)

  • 1. Perioperative safety of tofacitinib in surgical ulcerative colitis patients.
    Lightner AL; Vaidya P; Holubar S; Warusavitarne J; Sahnan K; Carrano FM; Spinelli A; Zaghiyan K; Fleshner PR
    Colorectal Dis; 2021 Aug; 23(8):2085-2090. PubMed ID: 33942470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rates of Adverse Events in Patients With Ulcerative Colitis Undergoing Colectomy During Treatment With Tofacitinib vs Biologics: A Multicenter Observational Study.
    Dragoni G; Innocenti T; Amiot A; Castiglione F; Melotti L; Festa S; Savarino EV; Truyens M; Argyriou K; Noviello D; Molnar T; Bouillon V; Bezzio C; Eder P; Fernandes S; Kagramanova A; Armuzzi A; Oliveira R; Viola A; Ribaldone DG; Drygiannakis I; Viganò C; Calella F; Gravina AG; Pugliese D; Chaparro M; Ellul P; Vieujean S; Milla M; Caprioli F;
    Am J Gastroenterol; 2024 Aug; 119(8):1525-1535. PubMed ID: 38305302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colectomy is a risk factor for venous thromboembolism in ulcerative colitis.
    Kaplan GG; Lim A; Seow CH; Moran GW; Ghosh S; Leung Y; Debruyn J; Nguyen GC; Hubbard J; Panaccione R
    World J Gastroenterol; 2015 Jan; 21(4):1251-60. PubMed ID: 25632199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tofacitinib for Rescue Therapy in Acute Severe Ulcerative Colitis: A Real-world Experience.
    Kotwani P; Terdiman J; Lewin S
    J Crohns Colitis; 2020 Jul; 14(7):1026-1028. PubMed ID: 32020189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tofacitinib for ulcerative colitis: results of the prospective Dutch Initiative on Crohn and Colitis (ICC) registry.
    Biemans VBC; Sleutjes JAM; de Vries AC; Bodelier AGL; Dijkstra G; Oldenburg B; Löwenberg M; van Bodegraven AA; van der Meulen-de Jong AE; de Boer NKH; Srivastava N; West RL; Römkens TEH; Horjus Talabur Horje CS; Jansen JM; van der Woude CJ; Hoekstra J; Weersma RK; van Schaik FDM; Hoentjen F; Pierik MJ;
    Aliment Pharmacol Ther; 2020 May; 51(9):880-888. PubMed ID: 32237087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tofacitinib Exposure Does Not Increase Postoperative Complications Among Patients With Ulcerative Colitis Undergoing Total Colectomy: A Retrospective Case-Control Study.
    Gomaa I; Aboelmaaty S; Bhatt H; Vierkant RA; Shawki SF; Larson DW; Behm KT; Rumer KK
    Dis Colon Rectum; 2024 Nov; 67(11):1443-1449. PubMed ID: 39087684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-world evidence of tofacitinib effectiveness and safety in patients with refractory ulcerative colitis.
    Lair-Mehiri L; Stefanescu C; Vaysse T; Laharie D; Roblin X; Rosa I; Treton X; Abitbol V; Amiot A; Bouguen G; Dib N; Fumery M; Pariente B; Carbonnel F; Peyrin-Biroulet L; Simon M; Viennot S; Bouhnik Y
    Dig Liver Dis; 2020 Mar; 52(3):268-273. PubMed ID: 31732444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Venous thromboembolic events in the tofacitinib ulcerative colitis clinical development programme.
    Sandborn WJ; Panés J; Sands BE; Reinisch W; Su C; Lawendy N; Koram N; Fan H; Jones TV; Modesto I; Quirk D; Danese S
    Aliment Pharmacol Ther; 2019 Nov; 50(10):1068-1076. PubMed ID: 31599001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged preoperative hospitalization correlates with worse outcomes after colectomy for acute fulminant ulcerative colitis.
    Coakley BA; Telem D; Nguyen S; Dallas K; Divino CM
    Surgery; 2013 Feb; 153(2):242-8. PubMed ID: 23062652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tofacitinib as salvage therapy for 55 patients hospitalised with refractory severe ulcerative colitis: A GETAID cohort.
    Uzzan M; Bresteau C; Laharie D; Stefanescu C; Bellanger C; Carbonnel F; Serrero M; Viennot S; Nachury M; Amiot A; Altwegg R; Picon L; Nahon S; Vuitton L; Ah Soune P; Kirchgesner J; Peyrin-Biroulet L; Bouhnik Y;
    Aliment Pharmacol Ther; 2021 Aug; 54(3):312-319. PubMed ID: 34151448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1-Year Comparative Effectiveness of Tofacitinib vs Ustekinumab for Patients With Ulcerative Colitis and Prior Antitumor Necrosis Factor Failure.
    Dalal RS; Sharma PP; Bains K; Pruce JC; Allegretti JR
    Inflamm Bowel Dis; 2024 Mar; 30(3):395-401. PubMed ID: 37209416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of venous and arterial thromboembolic events reported in the tofacitinib rheumatoid arthritis, psoriasis and psoriatic arthritis development programmes and from real-world data.
    Mease P; Charles-Schoeman C; Cohen S; Fallon L; Woolcott J; Yun H; Kremer J; Greenberg J; Malley W; Onofrei A; Kanik KS; Graham D; Wang C; Connell C; Valdez H; Hauben M; Hung E; Madsen A; Jones TV; Curtis JR
    Ann Rheum Dis; 2020 Nov; 79(11):1400-1413. PubMed ID: 32759265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tofacitinib Salvage Therapy for Children Hospitalized for Corticosteroid- and Biologic-Refractory Ulcerative Colitis.
    Constant BD; Baldassano R; Kirsch J; Mitchel EB; Stein R; Albenberg L
    J Pediatr Gastroenterol Nutr; 2022 Dec; 75(6):724-730. PubMed ID: 36122389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Portomesenteric Venous Thrombosis in Patients Undergoing Surgery for Medically Refractory Ulcerative Colitis.
    Kayal M; Radcliffe M; Plietz M; Rosman A; Greenstein A; Khaitov S; Sylla P; Dubinsky MC
    Inflamm Bowel Dis; 2020 Jan; 26(2):283-288. PubMed ID: 31372644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with postoperative morbidity, reoperation and readmission rates after laparoscopic total abdominal colectomy for ulcerative colitis.
    Gu J; Stocchi L; Remzi F; Kiran RP
    Colorectal Dis; 2013 Sep; 15(9):1123-9. PubMed ID: 23627886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative immunosuppression is not associated with increased postoperative complications following colectomy in children with colitis.
    Schaufler C; Lerer T; Campbell B; Weiss R; Cohen J; Sayej W; Hyams J
    J Pediatr Gastroenterol Nutr; 2012 Oct; 55(4):421-4. PubMed ID: 22395189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequential Use of High-Dose Tofacitinib After Infliximab Salvage Therapy in Acute Severe Ulcerative Colitis.
    Gilmore R; Hilley P; Srinivasan A; Choy M; De Cruz P
    J Crohns Colitis; 2022 Jan; 16(1):166-168. PubMed ID: 34159363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tofacitinib for Biologic-Experienced Hospitalized Patients With Acute Severe Ulcerative Colitis: A Retrospective Case-Control Study.
    Berinstein JA; Sheehan JL; Dias M; Berinstein EM; Steiner CA; Johnson LA; Regal RE; Allen JI; Cushing KC; Stidham RW; Bishu S; Kinnucan JAR; Cohen-Mekelburg SA; Waljee AK; Higgins PDR
    Clin Gastroenterol Hepatol; 2021 Oct; 19(10):2112-2120.e1. PubMed ID: 34048936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of postoperative complications among ulcerative colitis patients treated preoperatively with vedolizumab: a matched case-control study.
    Kim JY; Zaghiyan K; Lightner A; Fleshner P
    BMC Surg; 2020 Mar; 20(1):46. PubMed ID: 32138717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of tofacitinib treatment in ulcerative colitis.
    Panés J; Gisbert JP
    Gastroenterol Hepatol; 2019; 42(6):403-412. PubMed ID: 31101342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.